Application of proteomics for the identification of biomarkers in amniotic fluid: Are we ready to provide a reliable prediction?

EPMA Journal

Volumn 2, Issue 2, 2011, Pages 149-155

  Tsangaris, George Th ^a   Anagnostopoulos, Athanasios K ^a   Tounta, Georgia ^b   Antsaklis, Aris ^b   Mavrou, Ariadni ^b   Kolialexi, Aggeliki ^b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Amniotic fluid; Biomarkers; Fetal aneuploidies; Pregnancy complications; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

AMNION FLUID; AMNION FLUID ANALYSIS; AMNIONITIS; ANEUPLOIDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; FETUS DISEASE; HIGH THROUGHPUT SCREENING; HUMAN; INTRAUTERINE GROWTH RETARDATION; MASS SPECTROMETRY; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREMATURE LABOR; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS TECHNOLOGY; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEOMICS; REVIEW; SENSITIVITY ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 79961065861     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-011-0083-0     Document Type: Review

References (56)

1. Winslow RL, Boguski MS. Genome informatics: current status and future prospects. Circ Res. 2003; 92: 953-61.
2. Kulasingam V, Diamandis EP. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics. 2007; 6: 1997-2011.
3. Brewis IA. Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum Reprod. 1999; 14: 2927-9.
4. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction. 2002; 123: 487-95.
5. Rockett JC. Genomic and proteomic techniques applied to reproductive biology. Genome Biol. 2001; 2: REPORTS4020.
6. Coonrod SA, Wright PW, Herr JC. Oolemmal proteomics. J Reprod Immunol. 2002; 53: 55-65.
7. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab. 2002; 87: 2431-4.
8. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril. 1999; 71: 482-9.
9. Shankar R, Cullinane F, Brennecke SP, Moses EK. Applications of proteomic methodologies to human pregnancy research: a growing gestation approaching delivery? Proteomics. 2004; 4: 1909-17.
10. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY, et al. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics. 2006; 6: 3445-54.
11. Jauniaux E, Greenwold N, Hempstock J, Burton GJ. Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril. 2003; 79: 100-6.
12. Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol. 1997; 40: 280-9.
13. Sohaey R. Amniotic fluid and the umbilical cord: the fetal milieu and lifeline. Semin Ultrasound CT MR. 1998; 19: 355-69.
14. Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am J Perinatol. 2002; 19: 253-66.
15. Irving-Rodgers HF, Roger J, Luck MR, Rodgers RJ. Extracellular matrix of the corpus luteum. Semin Reprod Med. 2006; 24: 242-50.
16. Orczyk-Pawilowicz M, Florianski J, Zalewski J, Katnik-Prastowska I. Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age. Glycoconj J. 2005; 22: 433-42.
17. Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Ho PC, et al. Roles of glycodelin in modulating sperm function. Mol Cell Endocrinol. 2006; 250: 149-56.
18. Michel PE, Crettaz D, Morier P, Heller M, Gallot D, Tissot JD, et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis. 2006; 27: 1169-81.
19. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 785: 263-75.
20. Merrell K, Southwick K, Graves SW, Esplin MS, Lewis NE, Thulin CD. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J Biomol Tech. 2004; 15: 238-48.
21. Han X, Aslanian A, Yates 3rd JR. Mass spectrometry for proteomics. Curr Opin Chem Biol. 2008; 12: 483-90.
22. Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, Mazaki-Tovi S, et al. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2010; 23: 261-80.
23. Fountoulakis M, Langen H. Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem. 1997; 250: 153-6.
24. Liberatori S, Bini L, De Felice C, Magi B, Marzocchi B, Raggiaschi R, et al. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis. 1997; 18: 2816-22.
25. Heller M, Michel PE, Morier P, Crettaz D, Wenz C, Tissot JD, et al. Two-stage Off-Gel isoelectric focusing: protein followed by peptide fractionation and application to proteome analysis of human plasma. Electrophoresis. 2005; 26: 1174-88.
26. Nilsson S, Ramstrom M, Palmblad M, Axelsson O, Bergquist J. Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res. 2004; 3: 884-9.
27. Oh JE, Fountoulakis M, Juranville JF, Rosner M, Hengstschlager M, Lubec G. Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics. 2004; 4: 1145-58.
28. Jin J, Gao Z, Guo L, Yang J, Yu Y. Altered expression of zinc finger proteins, ADAMs, and integrin-related proteins following treatment of cultured human cells with a low concentration of N-methyl-N'-nitro-N-nitrosoguanidine. Environ Mol Mutagen. 2003; 41: 344-52.
29. Tsangaris G, Weitzdorfer R, Pollak D, Lubec G, Fountoulakis M. The amniotic fluid cell proteome. Electrophoresis. 2005; 26: 1168-73.
30. Tsangaris GT, Kolialexi A, Karamessinis PM, Anagnostopoulos AK, Antsaklis A, Fountoulakis M, et al. The normal human amniotic fluid supernatant proteome. In Vivo. 2006; 20: 479-90.
31. Queloz PA, Crettaz D, Thadikkaran L, Sapin V, Gallot D, Jani J, et al. Proteomic analyses of amniotic fluid: potential applications in health and diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 850: 336-42.
32. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics. 2007; 6: 1406-15.
33. Wang TH, Chang YL, Peng HH, Wang ST, Lu HW, Teng SH, et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn. 2005; 25: 559-66.
34. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics. 2006; 6: 4410-9.
35. Mavrou A, Anagnostopoulos AK, Kolialexi A, Vougas K, Papantoniou N, Antsaklis A, et al. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J Proteome Res. 2008; 7: 1862-6.
36. Anagnostopoulos AK, Kolialexi A, Mavrou A, Vougas K, Papantoniou N, Antsaklis A, et al. Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses. J Proteomics. 2009; 73: 943-50.
37. Mange A, Desmetz C, Bellet V, Molinari N, Maudelonde T, Solassol J. Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids. Proteome Sci. 2008; 6: 1.
38. Wang TH, Chao AS, Chen JK, Chao A, Chang YL, Cheng PJ, et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril. 2009; 92: 96-107.
39. Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J Proteome Res. 9: 3574-82.
40. Park J, Cha DH, Jung JW, Kim YH, Lee SH, Kim Y, et al. Comparative proteomic analysis of human amniotic fluid supernatants with down syndrome using mass spectrometry. J Microbiol Biotechnol. 2010; 20: 959-67.
41. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG. 2003; 110 Suppl 20: 3-7.
42. The hypertensive disorders of pregnancy. Report of a WHO study group. World Health Organ Tech Rep Ser. 1987; 758: 1-114.
43. Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol. 1999; 42: 422-35.
44. Vascotto C, Salzano AM, D'Ambrosio C, Fruscalzo A, Marchesoni D, di Loreto C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res. 2007; 6: 160-70.
45. Park JS, Oh KJ, Norwitz ER, Han JS, Choi HJ, Seong HS, et al. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci. 2008; 15: 457-68.
46. Wang CN, Chang SD, Peng HH, Lee YS, Chang YL, Cheng PJ, et al. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction. J Clin Endocrinol Metab. 2010; 95: 1431-41.
47. Wang CN, Chen JY, Sabu S, Chang YL, Chang SD, Kao CC, et al. Elevated amniotic fluid F(2)-isoprostane: A potential predictive marker for preeclampsia. Free Radic Biol Med. 2011; 50: 1124-30.
48. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004; 292: 462-9.
49. Bujold E, Romero R, Kusanovic JP, Erez O, Gotsch F, Chaiworapongsa T, et al. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med. 2008; 21: 697-713.
50. Buhimschi CS, Buhimschi IA, Abdel-Razeq S, Rosenberg VA, Thung SF, Zhao G, et al. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res. 2007; 61: 318-24.
51. Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG. 2009; 116: 257-67.
52. Buhimschi CS, Rosenberg VA, Dulay AT, Thung S, Sfakianaki AK, Bahtiyar MO, et al. Multidimensional system biology: genetic markers and proteomic biomarkers of adverse pregnancy outcome in preterm birth. Am J Perinatol. 2008; 25: 175-87.
53. Park SJ, Yoon WG, Song JS, Jung HS, Kim CJ, Oh SY, et al. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics. 2006; 6: 349-63.
54. Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res. 2005; 4: 2236-42.
55. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics. 2003; 3: 1521-5.
56. Thadikkaran L, Crettaz D, Siegenthaler MA, Gallot D, Sapin V, Iozzo RV, et al. The role of proteomics in the assessment of premature rupture of fetal membranes. Clin Chim Acta. 2005; 360: 27-36.